TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034
FDA Device Recall #Z-1310-2022 — Class II — April 26, 2022
Recall Summary
| Recall Number | Z-1310-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 26, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Haemonetics Corporation |
| Location | Boston, MA |
| Product Type | Devices |
| Quantity | 3933 kits (US); 2429 kits (OUS) |
Product Description
TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034
Reason for Recall
Due to a shift in the citrated blood reference range for a normal population, the ranges stated in the IFU are changing. If the clinician relies solely on affected results in comparison to the normal donor reference range, it could lead to misdiagnosis and incorrect treatment or failure to treat.
Distribution Pattern
Domestic distribution US Nationwide.
Lot / Code Information
UDI-DI: (01)20812747018095 All lots are affected.
Other Recalls from Haemonetics Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1298-2022 | Class II | Product Name: TEG5000 Analyzer (07-022, 07-033)... | Apr 19, 2022 |
| Z-1617-2020 | Class II | TEG Manager software versions used in conjuncti... | Feb 19, 2020 |
| Z-0904-2020 | Class II | JAPAN CELL SAVER ELITE SET - 225ML - Product Us... | Oct 21, 2019 |
| Z-0890-2020 | Class II | CS5/5+ Fastpacks, 225 mL, 20¿ Res Autotransfusi... | Oct 21, 2019 |
| Z-0900-2020 | Class II | JAPAN DISP SET, 261J, 205J, HAR - Product Usage... | Oct 21, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.